MicroBase Technology Corp. (TPEX:3184)

Market Cap	712.74M -26.3%
Revenue (ttm)	217.32M +0.2%
Net Income	47.81M -25.4%
EPS	0.75 -26.1%
Shares Out	63.07M
PE Ratio	15.05
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	105,551
Average Volume	234,646
Open	11.80
Previous Close	11.30
Day's Range	11.55 - 12.40
52-Week Range	8.40 - 15.40
Beta	0.39
RSI	61.48
Earnings Date	Mar 30, 2026

About MicroBase Technology

MicroBase Technology Corp. engages in the research, design, manufacture, and sale of components and products of micro-atomization and micro-needles for medical, cosmetic and electronic applications in Taiwan. The company develops non-silicon-based micro-electro-mechanical systems. It offers industrial inkjet head; soft mist inhaler, for the treatment of chronic obstructive pulmonary disease, lower respiratory tract infections, and chronic respiratory diseases; Pocket Air, an aerosol drug delivery solution; and soluble and insoluble microneedles...

• Industry: Electronic Components
• Sector: Technology
• Founded: 1997
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 3184

Financial Performance

In 2024, MicroBase Technology's revenue was 214.76 million, an increase of 10.28% compared to the previous year's 194.75 million. Earnings were 69.44 million, an increase of 82.22%.